Skip To Main Content
Ibiayi Dagogo-Jack on Muck Rack

Ibiayi Dagogo-Jack

As seen in: Nature, ScienceDirect, The Oncologist, JAMA Oncology, The Lancet, The ASCO Post, OncLive, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ibiayi

Contact Ibiayi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression

|
By Ibiayi Dagogo-Jack, Ru-Chen Xu, Ji-Min Zhu
| ScienceDirect Verified
Introduction Pancreatic cancer is an aggressive disease with a five-year survival rate of 13%.1 Deaths from pancreatic cancer are increasing, and it has been predicted that pancreatic cancer will become the second leading cause of cancer death in the United States and in parts of Europe by the year 2030.2,3,4,5 Early detection has dramatically reduced deaths from other cancer types, and the survival rate of patients with low-stage pancreatic cancer is significantly higher than that of those...
Open in Who Shared Issue with article?

Refreshing the mesothelioma catalogue: tailoring cellular therapy in the DENIM trial

|
By Marjorie G. Zauderer, Ibiayi Dagogo-Jack
| The Lancet Verified
MesoPher did not show improvement in overall survival in patients with pleural mesothelioma. Immune checkpoint therapy is now standard of care in pleural mesothelioma. Further randomised studies are needed of combinations of MesoPher and immune checkpoint therapy, which might increase efficacy without adding major toxicities.
Open in Who Shared Issue with article?

Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape

|
By Ibiayi Dagogo-Jack, Russell Madison, Jochen K. Lennerz, Kuei-Ting Chen
| ascopubs.org
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript.
Open in Who Shared Issue with article?
See all 15 licensed articles (19 Total)